Baldwin S, Hall C, Bennell C, Blaskovits B, Lawrence C. Distinguishing features of excited delirium syndrome in non-fatal use of force encounters. J Forensic Legal Med. 2016;41:21–7.
Hall C, Votova K, Heyd C, Walker M, Macdonald S, Eramian D, et al. Restraint in police use of force events: examining sudden in custody death for prone and not-prone positions. J Forensic Legal Med. 2015;31:29–35.
Hall CA, Kader AS, McHale AMD, Stewart L, Fick GH, Vilke GM. Frequency of signs of excited delirium syndrome in subjects undergoing police use of force: descriptive evaluation of a prospective, consecutive cohort. J Forensic Legal Med. 2013;20:102–7.
Mash DC, Duque L, Pablo J, Qin Y, Adi N, Hearn WL, et al. Brain biomarkers for identifying excited delirium as a cause of sudden death. Forensic Sci Int. 2009;190:e13–9.
Byard RW. Ongoing issues with the diagnosis of excited delirium. Forensic Sci Med Pathol. 2017;14:149–51.
Takeuchi A, Ahern TL, Henderson SO. Excited delirium. West J Emerg Med. 2011;12:77–83.
Pollanen MS, Chiasson DA, Cairns JT, Young JG. Unexpected death related to restraint for excited delirium: a retrospective study of deaths in police custody and in the community. CMAJ. 1998;158:1603–7.
Wetli CV, Fishbain D. Cocaine-induced psychosis and sudden death in recreational cocaine users. J Forensic Sci. 1985;30:873–80.
Di Maio TG, Di Maio VJ. Excited delirium syndrome cause of death and prevention. Boca Raton: CRC Press, Taylor & Francis; 2006.
Gordon C, Schmelzer M. Care of the patient in excited delirium. J Emerg Nurs. 2013;39:190–6.
Karch SB, Stephens BG. Drug abusers who die during arrest or in custody. J R Soc Med. 1999;92:12–5.
Otahbachi M, Cevik C, Bagdure S, Nugent K. Excited delirium, restraints, and unexpected death: a review of pathogenesis. Am J Forensic Med Pathol. 2010;31:107–12.
Byard RW. The relationship between positional asphyxia and increasing body mass index. Legal Med. 2020;43:101678.
Stratton S, Rogers C, Brickett K, Grunzinski G. Factors associated with sudden death of individuals requiring restraint for excited delirium. Am J Emerg Med. 2001;19:187–91.
Southall PE, Grant JR, Fowler DR, Scott SR. Police custody deaths in Maryland, USA: an examination of 45 cases. J Forensic Legal Med. 2008;15:227–30.
Sullivan L. Death by excited delirium: diagnosis or coverup? 2007. https://www.npr.org/templates/story/story.php?storyId=7608386. Accessed 23 April 2020.
Ranson D. Excited delirium syndrome: a political diagnosis? J Law Med. 2012;19:667–72.
Vilke GM, Debard ML, Chan TC, Ho JD, Dawes DM, Hall C, et al. Excited delirium syndrome (ExDS): defining based on a review of the literature. J Emerg Med. 2012;43:897–905.
Imam SF, Patel H, Mahmoud M, Prakash NA, King MS, Fremont RD. Bath salts intoxication: a case series. J Emerg Med. 2013;45:361–5.
Storey M. Explaining the unexplainable: excited delirium syndrome and its impact on the objective reasonableness standard for allegations of excessive force. St Louis Univ Law J. 2012;56:633–63.
Gonin P, Beysard N, Yersin B, Carron P. Excited delirium: a systematic review. Acad Emerg Med. 2018;25:552–65.
Moher D, Liberati A, Tetzlaff J, Altman D, Group TP. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ Open. 2009;339:b2535.
Price T, O’Neill RM. EMS, crime scene responsibility. StatPearls 2019.
Aberegg S, Erickson B, Cowan M. A 26-year-old man with substance abuse, agitation, and pneumomediastinum. J Lung Pulm Respir Res. 2014;1:1–3.
Alciati A, Scaramelli B, Fusi A, Butteri E, Cattaneo ML, Mellado C. Three cases of delirium after “ecstasy” ingestion. J Psychoactive Drugs. 1999;31:167–70.
Atherton D, Dye D, Robinson CA, Beck R. n-Ethyl pentylone-related deaths in Alabama. J Forensic Sci. 2019;64:304–8.
Benzer TI, Nejad SH, Flood JG. Case 40-2013: a 36-year-old man with agitation and paranoia. N Engl J Med. 2013;369:2536–45.
Blaho K, Winbery S, Park L, Logan B, Karch SB, Barker LA. Cocaine metabolism in hyperthermic patients with excited delirium. J Clin Forensic Med. 2000;7:71–6.
Bozeman WP, Ali K, Winslow JE. Long QT syndrome unmasked in an adult subject presenting with excited delirium. J Emerg Med. 2013;44:e207–10.
Bunai Y, Akaza K, Jiang WX, Nagai A. Fatal hyperthermia associated with excited delirium during an arrest. Legal Med. 2008;10:306–9.
Burnett AM, Watters BJ, Barringer KW, Griffith KR, Frascone RJ. Laryngospasm and hypoxia after intramuscular administration of ketamine to a patient in excited delirium. Prehospital Emerg Care. 2012;16:412–4.
Byard R, Cox M, Stockham P. Blunt craniofacial trauma as a manifestation of excited delirium caused by new psychoactive substances. J Forensic Sci. 2016;61:1546–8.
Corstens D. Excited delirium syndrome after withdrawal from 10 days long recreationally used GHB. J Forensic Legal Med. 2018;54:74–5.
Daugherty J. Acceptance and recognition of excited delirium by law enforcement agencies. 2012. http://hdl.handle.net/20.500.11875/1819. Accessed 23 April 2020.
Debelmas A, Benchetrit D, Galanaud D, Khonsari RH. Case 251: nontraumatic drug-associated rhabdomyolysis of head and neck muscles. Radiology. 2018;286:1088–92.
Desharnais B, Dazé Y, Huppertz LM, Mireault P, Skinner CD. A case of fatal idiosyncratic reaction to the designer drug 3,4-methylenedioxypyrovalerone (MDPV) and review of the literature. Forensic Sci Med Pathol. 2017;13:350–4.
Downes MA, Berling IL, Mostafa A, Grice J, Roberts MS, Isbister GK. Acute behavioural disturbance associated with phenibut purchased via an internet supplier. Clin Toxicol. 2015;53:636–8.
Dyer JE, Roth B, Hyma BA. Gamma-hydroxybutyrate withdrawal syndrome. Ann Emerg Med. 2001;37:147–53.
Feeney C, Vu J, Ani C. Acute agitated delirious state associated with taser exposure. J Natl Med Assoc. 2010;102:1254–7.
Fishbain D, Wetli C. Cocaine intoxication, delirium, and death in a body packer. Ann Emerg Med. 1981;10:531–2.
Ho JD, Smith SW, Nystrom PC, Dawes DM, Orozco BS, Cole JB, et al. Successful management of excited delirium syndrome with prehospital ketamine: two case examples. Prehospital Emerg Care. 2012;17:274–9.
Jovel A, Felthous A, Bhattacharyya A. Delirium due to intoxication from the novel synthetic tryptamine 5-meo-dalt. J Forensic Sci. 2014;59:844–6.
Kasick DP, McKnight CA, Klisovic E. “Bath salt” ingestion leading to severe intoxication delirium: two cases and a brief review of the emergence of mephedrone use. Am J Drug Alcohol Abuse. 2012;38:176–80.
Kennedy DB, Savard DM. Delayed in-custody death involving excited delirium. J Correct Heal Care. 2017;24:43–51.
Kesha K, Boggs CL, Ripple MG, Allan CH, Levine B, Jufer-Phipps R, et al. Methylenedioxypyrovalerone (“bath salts”) related death: case report and review of the literature. J Forensic Sci. 2013;58:1654–9.
Kiely E, Lee CJ, Marinetti L. A fatality from an oral ingestion of methamphetamine. J Anal Toxicol. 2009;33:557–60.
Kodikara S, Cunningham K, Pollanen MS. “Excited delirium syndrome” : Is it a cause of death? Legal Med. 2012;14:252–4.
Kowalski JM, Kopec KT, Lavelle J, Osterhoudt K. A novel agent for management of agitated delirium. Pediatr Emerg Care. 2017;33:e58–62.
Kristofic JJ, Chmiel JD, Jackson GF, Vorce SP, Holler JM, Robinson SL, et al. Detection of 25C-NBOMe in three related cases. J Anal Toxicol. 2016;40:466–72.
Kunz SN, Þórðardóttir S, Rúnarsdóttir R. Restraint-related asphyxia on the basis of a drug-induced excited delirium. Forensic Sci Int. 2018;288:e5–9.
Labay LM, Caruso JL, Gilson TP, Phipps RJ, Knight LD, Lemos NP, et al. Synthetic cannabinoid drug use as a cause or contributory cause of death. Forensic Sci Int. 2016;260:31–9.
Lucena J, Blanco M, Jurado C, Rico A, Salguero M, Vazquez R, et al. Cocaine-related sudden death: a prospective investigation in south-West Spain. Eur Heart J. 2010;31:318–29.
Lusthof KJ, Oosting R, Maes A, Verschraagen M, Dijkhuizen A, Sprong AGA. A case of extreme agitation and death after the use of mephedrone in the Netherlands. Forensic Sci Int. 2011;206:e93–5.
Maher PJ, Walsh M, Burns T, Strote J. Prehospital resuscitation of a man with excited delirium and cardiopulmonary arrest. Can J Emerg Med. 2014;16:80–3.
Mash DC, Staley JK, Izenwasser S, Basile M, Ruttenber AJ. Serotonin transporters upregulate with chronic cocaine use. J Chem Neuroanat. 2000;20:271–80.
McDaniel CH, Miotto KA. Gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal: five case studies. J Psychoactive Drugs. 2001;33:143–9.
Menaker J, Farcy DA, Boswell SA, Stein DM, Dutton RP, Hess JR, et al. Cocaine-induced agitated delirium with associated hyperthermia: a case report. J Emerg Med. 2011;41:e49–53.
Miller C. A restraint asphyxia “near-death” case study. Restraint Asphyxia Newz Dir. 1998;1998:1–17.
Mirchandani H, Rorke L, Sekula-Perlman A, Hood I. Cocaine-induced agitated delirium, forceful struggle, and minor head injury. Am J Forensic Med Pathol. 1994;15:95–9.
Morrison A, Sadler D. Death of a psychiatric patient during physical restraint. Excited delirium - a case report. Med Sci Law. 2001;41:46–50.
Murphy CM, Dulaney AR, Beuhler MC, Kacinko S. “Bath salts” and “plant food” products: the experience of one regional US poison center. J Med Toxicol. 2012;9:42–8.
Murray BL, Murphy CM, Beuhler MC. Death following recreational use of designer drug “bath salts” containing 3,4-Methylenedioxypyrovalerone (MDPV). J Med Toxicol. 2012;8:69–75.
O’Halloran RL, Lewman LV. Restraint asphyxiation in excited delirium. Am J Forensic Med Pathol. 1993;14:289–95.
O’Halloran RL, Frank JG. Asphyxial death during prone restraint revisited: a report of 21 cases. Am J Forensic Med Pathol. 2000;21:39–52.
Park K, Korn C, Henderson SO. Agitated delirium and sudden death: two case reports. Prehospital Emerg Care. 2001;5:214–6.
Penders TM, Gestring RE, Vilensky DA. Intoxication delirium following use of synthetic cathinone derivatives. Am J Drug Alcohol Abuse. 2012;38:616–7.
Pestaner JP, Southall PE. Sudden death during arrest and phencyclidine intoxication. Am J Forensic Med Pathol. 2003;24:119–22.
Plush T, Shakespeare W, Jacobs D, Ladi L, Sethi S, Gasperino J. Cocaine-induced agitated delirium: a case report and review. J Intensive Care Med. 2015;30:49–57.
Pritchard A, Le Cong M. Ketamine sedation during air medical retrieval of an agitated patient. Air Med J. 2014;33:76–7.
Rayamane A, Thejaswi H, Pradeepkumar M, Patra AP, Shaha KK. Case-series on death of physically restrained patients in de-addiction centers due to excited delirium syndrome. JIST. 2015;11:34–7.
Reichmuth P, Blanc AL, Tagan D. Unintentional baclofen intoxication in the management of alcohol use disorder. BMJ Case Rep. 2015;Online Pub:1–3.
Ruttenber AJ, McAnally HB, Wetli CV. Cocaine-associated rhabdomyolysis and excited delirium: different stages of the same syndrome. Am J Forensic Med Pathol. 1999;20:120–7.
Samuel E, Williams RB, Ferrell RB. Excited delirium: consideration of selected medical and psychiatric issues. Neuropsychiatr Dis Treat. 2009;5:61–6.
Scaggs TR, Glass DM, Hutchcraft MG, Weir WB. Prehospital ketamine is a safe and effective treatment for excited delirium in a community hospital based EMS system. Prehosp Disaster Med. 2016;31:563–9.
Schiavone S, Neri M, Mhillaj E, Pomara C, Trabace L, Turillazzi E. The role of the NADPH oxidase derived brain oxidative stress in the cocaine-related death associated with excited delirium: a literature review. Toxicol Lett. 2016;258:29–35.
Shields LBE, Rolf CM, Hunsaker JC. Sudden death due to acute cocaine toxicity-excited delirium in a body packer. J Forensic Sci. 2015;60:1647–51.
Śliwicka O, Szatnera K, Borowska–Solonynko A. Three postmortem case reports of the excited delirium syndrome – A short comparison. J Forensic Leg Med. 2019;66:134–7.
Stratton SJ, Rogers C, Green K. Sudden death in individuals in hobble restraints during paramedic transport. Ann Emerg Med. 1995;25:710–2.
Sztajnkrycer MD, Baez AA. Cocaine, excited delirium and sudden unexpected death. Emerg Med Serv. 2005;34:77–81.
Wiebe T, Sigurdson E, Katz L. Angel’s trumpet (Datura stramonium) poisoning and delirium. Paediatr Child Heal. 2008;13:193–6.
Cole JB, Klein LR, Nystrom PC, Moore JC, Driver BE, Fryza BJ, et al. A prospective study of ketamine as primary therapy for prehospital profound agitation. Am J Emerg Med. 2018;36:789–96.
Ezaki J, Ro A, Hasegawa M, Kibayashi K. Fatal overdose from synthetic cannabinoids and cathinones in Japan: demographics and autopsy findings. Am J Drug Alcohol Abuse. 2016;42:520–9.
Grant JR, Southall PE, Mealey J, Scott SR, Fowler DR. Excited delirium deaths in custody: past and present. Am J Forensic Med Pathol. 2009;30:1–5.
Gray SD, Fatovich DM, Mccoubrie DL, Daly FF, Medical T. Amphetamine-related presentations to an inner-city tertiary emergency department: a prospective evaluation. Med J Aust. 2007;186:336–9.
Ho JD, Heegaard WG, Dawes DM, Natarajan S, Reardon R, Miner JR. Unexpected arrest-related deaths in America: 12 months of open source surveillance. West J Emerg Med. 2009;10:68–73.
Li M, Martinelli AN, Oliver WD, Wilkerson RG. Evaluation of ketamine for excited delirium syndrome in the adult emergency department. J Emerg Med. 2019. https://doi.org/10.1016/j.jemermed.2019.09.019.
Michaud A. Restraint related deaths and excited delirium syndrome in Ontario (2004-2011). J Forensic Legal Med. 2016;41:30–5.
Miner JR, Klein LR, Cole JB, Driver BE, Moore JC, Ho JD. The characteristics and prevalence of agitation in an urban county emergency department. Ann Emerg Med. 2018;72:361–70.
Mo H, Campbell MJ, Lam SW, Wells EJ, Casserly E, Meldon SW. Ketamine safety and use in the emergency department for pain and agitation / delirium : A health system experience 2020;21:10–2.
Ross DL. Factors associated with excited delirium deaths in police custody. Mod Pathol. 1998;11:1127–37.
Ruttenber AJ, Lawler-Heavner J, Yin M, Wetli CV, Hearn WL, Mash DC. Fatal excited delirium following cocaine use: epidemiologic findings provide new evidence for mechanisms of cocaine toxicity. J Forensic Sci. 1997;42:14064J.
Strote J, Walsh M, Auerbach D, Burns T, Maher P. Medical conditions and restraint in patients experiencing excited delirium. Am J Emerg Med. 2014;32:1093–6.
Strote J, Hutson HR. Taser use in restraint-related deaths. Prehospital Emerg Care. 2006;10:447–50.
Vilke GM, Mash DC, Pardo M, Bozeman W, Hall C, Sloane C, et al. EXCITATION study: unexplained in-custody deaths: evaluating biomarkers of stress and agitation. J Forensic Legal Med. 2019;66:100–6.
Meth Facts, History and Statistics | Dangers and Legality. https://drugabuse.com/methamphetamine/history-statistics/. Accessed 23 April 2020.
State of knowledge of drug impaired driving. DOT HS 809 642. https://rosap.ntl.bts.gov/view/dot/1722. Accessed 23 April 2020.
DeBard ML, Adler J, Bozeman WP, Chan TC, Coffman SR, Costello MW, et al. White paper report on excited delirium syndrome. Am Coll Emerg Physicians. 2009. https://www.prisonlegalnews.org/media/publications/acep_report_on_excited_delirium_syndrome_sept_2009.pdf. Accessed 23 April 2020.
Barnett JH, Werners U, Secher SM, Hill KE, Brazil R, Masson K, et al. Substance use in a population-based clinic sample of people with first-episode psychosis. Br J Psychiatry. 2007;190:515–20.
Chan TC, Vilke GM, Neuman T, Clausen JL. Restraint position and positional asphyxia. Ann Emerg Med. 1997;30:578–86.
Chan TC, Neuman T, Clausen J, Eisele J, Vilke GM. Weight force during prone restraint and respiratory function. Am J Forensic Med Pathol. 2004;25:185–9.
Michalewicz BA, Chan TC, Vilke GM, Levy SS, Neuman TS, Kolkhorst FW. Ventilatory and metabolic demands during aggressive physical restraint in healthy adults. J Forensic Sci. 2007;52:171–5.
Savaser DJ, Campbell C, Castillo EM, Vilke GM, Sloane C, Neuman T, et al. The effect of the prone maximal restraint position with and without weight force on cardiac output and other hemodynamic measures. J Forensic Legal Med. 2013;20:991–5.
Healthcare Cost and Utilization Project (HCUP). 2019. https://www.hcup-us.ahrq.gov. Accessed 23 April 2020.